We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




High Blood Glucose Levels Linked to Dementia

By LabMedica International staff writers
Posted on 22 Aug 2013
Adults with a high blood sugar level may have an increased risk of developing dementia compared with those who have a normal blood sugar level. More...


With the aging of the population, dementia has become a major threat to public health worldwide, while the rate of obesity is also increasing, with a parallel increase in the rate of diabetes.

Scientists at the University of Washington School of Medicine (Seattle, WA, USA) analyzed various variables of 2,067 participants without dementia aged 65 and over. In order to examine the relationship between glucose levels and the risk of dementia, they analyzed the median measurements of glycated hemoglobin levels (HbA1C) and glucose levels over a period of 6.8 years.

The results of the study revealed that in the participants with diabetes, the risk of dementia was 40% higher for those with an average glucose level of 190 mg/dL, compared with participants who had an average glucose level of 160 mg/dL. The results also showed that in the participants without diabetes, the risk of dementia was 18% higher for those with an average glucose level of 115 mg/dL versus those with an average of 100 mg/dL.

The investigators said that including both glucose levels and glycated hemoglobin in the measurements was the key as blood sugar levels rise and fall throughout the day, but glycated hemoglobin does not vary as much over short periods. However, they add that these results do not necessarily mean that people should eat foods with a lower "glycemic index," but exercise may help.

Paul K. Crane, MD, MPH, an associate professor and lead author, said, “The most interesting finding was that every incrementally higher glucose level was associated with a higher risk of dementia in people who did not have diabetes. There was no threshold value for lower glucose values where risk leveled off. Your body turns your food into glucose, so your blood sugar levels depend not only on what you eat but also on your individual metabolism: how your body handles your food."

The authors concluded that although their results show that higher glucose levels are linked to higher dementia risk, there is no data to suggest people who make changes to lower their glucose levels will reduce the risk of dementia. The study was published on August 8, 2013, in the New England Journal of Medicine (NEJM).

Related Links:

University of Washington School of Medicine



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.